EGR1 and myeloid neoplasm: Of note is that the incidence of myeloid disease is higher in Egr1+/− mice (68%) than in WT mice (49%), indicating that loss of one allele of Egr1 shifts the disease spectrum from the more common lymphoid neoplasm to myeloid neoplasms.